Combining familial hypercholesterolemia and statin genetic studies as a strategy for the implementation of pharmacogenomics. A multidisciplinary approach

Ramudo-Cela, L; Santana-Martinez, S; Garcia-Ramos, M; Bergamino, M; Garcia-Giustiniani, D; Velez-Vieitez, P; Hernandez-Hernandez, JL; Garcia-Ibarbia, C; Gonzalez-Bustos, P; Ruiz-Martin, P; Gonzalez-Lozano, J; Santome-Collazo, L; Grana-Fernandez, A; Cabaleiro-Cervino, P; Ortiz, M; Monserrat-Iglesias, L

Ramudo-Cela, L (通讯作者),Hlth Code SL, Sci Dept, La Coruna, Spain.;Ramudo-Cela, L (通讯作者),Complexo Hosp Univ A Coruna, La Coruna, Spain.;Ramudo-Cela, L (通讯作者),Univ A Coruna, La Coruna, Spain.

PHARMACOGENOMICS JOURNAL, 2022; 22 (3): 180

Abstract

The diagnostic process of familial hypercholesterolemia frequently involves the use of genetic studies. Patients are treated with lipid-lowering drugs......

Full Text Link